12-49484607-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_023071.4(SPATS2):​c.43T>G​(p.Phe15Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

SPATS2
NM_023071.4 missense

Scores

5
10
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.03
Variant links:
Genes affected
SPATS2 (HGNC:18650): (spermatogenesis associated serine rich 2) Enables RNA binding activity. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATS2NM_023071.4 linkc.43T>G p.Phe15Val missense_variant Exon 4 of 14 ENST00000552918.6 NP_075559.2 Q86XZ4A0A024R101

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATS2ENST00000552918.6 linkc.43T>G p.Phe15Val missense_variant Exon 4 of 14 2 NM_023071.4 ENSP00000447947.2 Q86XZ4

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 02, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.43T>G (p.F15V) alteration is located in exon 4 (coding exon 2) of the SPATS2 gene. This alteration results from a T to G substitution at nucleotide position 43, causing the phenylalanine (F) at amino acid position 15 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Pathogenic
0.46
D
BayesDel_noAF
Pathogenic
0.43
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
.;T;T;T;.;T;T;.;T;T
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.86
D;D;D;D;D;.;.;D;D;T
M_CAP
Benign
0.0087
T
MetaRNN
Uncertain
0.48
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.6
.;.;.;.;.;M;M;.;M;.
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-2.9
D;D;D;D;D;N;N;D;N;D
REVEL
Uncertain
0.33
Sift
Uncertain
0.0040
D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D;D;D
Polyphen
0.99
.;.;.;.;.;D;D;.;D;.
Vest4
0.85, 0.81
MutPred
0.27
Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);Gain of MoRF binding (P = 0.1764);
MVP
0.33
MPC
0.86
ClinPred
0.99
D
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.35
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-49878390; API